A carregar...
SGLT2 Inhibition in the Diabetic Kidney—From Mechanisms to Clinical Outcome
Diabetic kidney disease not only has become the leading cause for ESRD worldwide but also, highly contributes to increased cardiovascular morbidity and mortality in type 2 diabetes. Despite increased efforts to optimize renal and cardiovascular risk factors, like hyperglycemia, hypertension, obesity...
Na minha lista:
| Publicado no: | Clin J Am Soc Nephrol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Nephrology
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5383382/ https://ncbi.nlm.nih.gov/pubmed/28254770 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.06080616 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|